Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+38.8%
5Y CAGR+57.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+38.8%/yr
vs +54.7%/yr prior
5Y CAGR
+57.7%/yr
Recent deceleration
Acceleration
-15.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
9.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $189.59M | +30.0% |
| 2024 | $145.82M | +91.7% |
| 2023 | $76.06M | +7.3% |
| 2022 | $70.89M | +133.4% |
| 2021 | $30.37M | +56.1% |
| 2020 | $19.45M | -72.1% |
| 2019 | $69.59M | +462.5% |
| 2018 | $12.37M | - |